Further, glucose consumption, lactate production, and pyruvate production assays in the four NSCLC cell lines to evaluate the effect of FGL1 on tumor glycolysis revealed significant inhibition of glycolysis after FGL1 knockdown (P < 0.05; Fig. 5G). This evidence concerns the gene FGL1 and non-small cell lung carcinoma.